Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1072 (LINC01072) is a non-coding RNA gene in humans that produces a long non-coding transcript, classified as a lincRNA—meaning it does not overlap any protein-coding gene and is situated in the genome between coding regions[1][3][5]. LINC01072 has no currently described protein product, verified functions, or direct role in human disease. While the broader lincRNA family has been implicated in transcriptional regulation, epigenetic modification, and cell signaling across diverse physiological and pathological contexts[5][7], LINC01072 itself remains poorly characterized and is not considered a therapeutic drug target, biomarker, or clinical target at this time[1][3]. Its sequence, classification, and genetic identifiers are established in genomic databases, but functional studies or clinical associations have not been reported as of the current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1072 (LINC01072).